From Relief to Risk: BC Powder’s Impact on Chronic Salicylate Toxicity and Acute Respiratory Distress Syndrome

The transport of oxygen through the placenta is a complex process and the greatest danger to the fetus of a pregnant woman with asthma is insufficient therapy and control of asthma. Most diagnostic procedures for evaluating the function of the respiratory system during pregnancy are not harmful to the fetus. Except for the forced expiratory volume in the first second, the other pulmonary function tests are reduced and decrease with the progress of pregnancy. Hyperventilation and dyspnea are normal phenomena, and pregnancy is not a contraindication for stopping exercise. However, in case of severe dyspnea, additional diagnostic tests should be performed. Bronchoprovocation tests, ventilation-perfusion scintigraphic scans and cardio-pulmonary stress tests should be avoided, and forced expiratory tests should also be avoided in the later stages of pregnancy. Daily measurement of peak expiratory flow is simple, safe, inexpensive, and very informative in determining the control and therapy of pregnant women’s asthma.

Keywords: Salicylate; Acute Respiratory Distress Syndrome; BC Powder; Toxicology; Drug Toxicity